The management of a group of epilepsy patients from primary care, in a geographical area with clear epilepsy management guidelines and secondary care clinics is surveyed. Suggestions are made to improve liaison between primary and secondary care as well as epilepsy management in primary care.
INTRODUCTION
Epilepsy is the most common serious neurological condition 1 . The report of the working group on Services for people with epilepsy 2 recommends that following initial diagnosis and treatment by a neurologist, epilepsy is a condition best managed in the primary care setting in the majority of cases. However, 'epilepsy remains under treated despite advances in the development of effective drug treatments, and many patients still receive inadequate or inappropriate therapy' 3 . Patients with epilepsy in primary care are treated if they attend their practice but are commonly not followed up if they fail to attend 3, 12 . Chappell and Smithson 4 found only 9% of patients had an organised regular review of their epilepsy and Moran et al. 5 found that many patients with severe epilepsy had received no primary care consultations in the previous year. Many patients with severe epilepsy did not receive any specialist input into their care and few patients with controlled epilepsy received regular medical supervision although they were taking anti-epilepsy drugs (AEDs).
Several government reports 2, 6 have suggested ways to improve epilepsy care including establishing epilepsy clinics in district general hospitals as well as the use of local guidelines aimed at improving overall care.
The aim of this study was to survey the care of epilepsy patients managed in the primary care setting in a geographical area where there is a well established epilepsy clinic with local guidelines for referral of patients for diagnosis and treatment.
METHOD
An 'Audit of epilepsy services in Northamptonshire' 7 was completed in response to the NHS executive letter EL (95)120 8 which was aimed at co-ordinating a number of initiatives to improve epilepsy services. This audit highlighted problems locally including poor review of patients in primary care, and a lack of communication and counselling available to patients.
The neurology team responded to this report by inviting local practices to participate in an epilepsy project. It commenced with a study day giving a broad overview of epilepsy management, targeted at practice nurses who it was anticipated would be most likely to complete the necessary audit. Interested GPs were also welcomed. Those practice nurses and GPs who attended were asked to commit to completing an audit to identify all patients in their practice with epilepsy, by database searches using diagnostic codes and prescribing data.
Identified patients were then offered an appointment for review by their practice nurse or GP. Patients were excluded if they were less than 16 years of age, as they would be under paediatric review. Patients already under specialist review were also excluded as the study was concentrating on reviewing management in the primary care setting.
At the practice review a patient assessment form was completed. This gathered information including patient details, description of attacks, frequency and date of last attack, medication and dosage, compliance, side effects, driving, employment, contraception and pregnancy. This form had trigger points to highlight patients who might benefit from a specialist review, e.g. patients prescribed the older AEDs or Vigabatrim (due to potential visual field defects), those whose compliance was poor or who suffered moderate to severe side effects, patients suffering regular seizures, planning pregnancy, or the patient simply requested the opportunity for specialist review.
Patient assessment forms were completed by the practice nurse or GP and forwarded to the epilepsy specialist nurse who allocated patients to six evening clinics, held monthly over a period of 6 months. The patients were reviewed by the consultant neurologist, clinical assistant or specialist nurse.
Recommendations for treatment change were made as appropriate following discussion with the patient. The GP and practice nurse were informed by letter with advice about implementing the recommended changes. The opportunity was also taken to discuss life style issues surrounding diagnosis and seizure type, contraception, pregnancy, driving and employment. An EEG technician was available during the clinics to carry out an EEG as necessary, and funding was available for scans if it was felt to be appropriate.
RESULTS
Of 42 local practices invited to take part in the project 12 practices attended the initial study day and 9 practices went ahead and surveyed their epilepsy populations. These 9 practices, with a patient population of 70 074 (23% of the county population), identified 506 patients prescribed AEDs (11.2% of the estimated 4500 patients with active epilepsy in the county).
After exclusion criteria were applied the remaining 303 patients (59%) were offered appointments for review by their practice nurse, of whom 116 patients (38%) attended. Of these 116 patients 76 patients (65%) were referred for specialist review and 71 patients (93%) attended.
Thirty-five male and 36 female patients were reviewed. Their ages ranged between 19 and 92 years with a mean age of 46. The most common seizure types reported were complex partial seizures and tonic/clonic seizures of a primary or secondary generalised nature. Date of diagnosis occurred between 1924 and 1999. Diagnosis was uncertain in 3 patients, 5 patients had learning disabilities, 1 patient had psychiatric problems and 2 patients had physical problems associated with a diagnosis of meningitis in one case and brain injury in the other. Eight patients had EEG recordings and 2 had CT scans following their review.
Thirty-one patients (43%) were seizure free (no seizures for 5 years). Thirty-two patients (45%) had suffered seizures in the previous year with 16 (22.5%) of these still suffering at least one seizure per month, with 5 patients suffering very frequent seizures (graph 1).
Most of the patients reviewed reported side effect problems including 29 patients (40%) reporting drowsiness, 20 patients (28%) reporting difficulties with concentration, 14 patients (19%) reporting aggression or agitation and 14 patients (19%) complaining of headache. On closer questioning it wasn't felt that all the side effect complaints were related to AEDs however.
Fifteen patients (21%) reported poor compliance and 10 patients (14%) had their medication regime adjusted to either a once or twice daily prescription instead of three or four times daily to improve compliance.
Ten patients (14%) had the dosage of their medication increased to improve fit control, 26 patients (36%) had medications stopped, 8 patients (11%) had new drugs commenced and 12 patients (16%) refused drug alterations (Tables 1 and 2 ). 
DISCUSSION
This study was only able to focus on a small number of self-chosen local primary care practices within Northamptonshire. It could therefore be argued that those practices that opted into the study did so because they were aware that their delivery of epilepsy care was inadequate and they wanted to improve provision of epilepsy management within primary care. In contrast the practices that chose not to be included in the study may have perceived that their provision of epilepsy management within the primary care setting adhered to good levels of practice. Inclusion into this study was further compounded by the factors affecting patient inclusion. Patients already receiving specialist review were excluded. This group is likely to include those with severe chronic epilepsy, as well as a greater number of patients on monotherapy and therefore fewer side effects as well as greater satisfaction with care 14 . Patient inclusion was dependent on the patient having a diagnosis of epilepsy and receiving prescription AEDs. Clearly the majority of patients who responded and attended the clinical reviews had either active epilepsy or inactive epilepsy that was controlled by medication. The chances of recruiting patients who were experiencing the most difficulties as a result of epilepsy and its treatment were therefore increased, although it would have been hoped that with clear local guidelines for epilepsy management and referral, these patients would have been under specialist review already. These compounding effects within the survey of specific primary care practices who felt they were not managing epilepsy care effectively, and a client group of people with active epilepsy, may in itself have created an inherently biased study that cannot be used for comparative research in primary care studies. It may, however, be construed that this survey is representative of the standard of epilepsy management in primary care throughout the country and further primary care studies of this type are needed to reinforce or dispute this viewpoint.
Of the study population 38% of the patients in the local primary care setting were continuing to take the older AEDs, (Phenytoin, Phenobarbitone and Primidone) when they may no longer have been required or when a newer AED might have been more suitable. These figures are comparable to other recent studies 9, 10 . The survey also suggests that with a little attention to detail it would have been possible to make slight adjustments to medication regimes and dosage of AEDs which could have lessened drug side effects and improved compliance and seizure control.
Chappell 4 , Jacoby 9 , and Freeman 11 have all found that GP confidence affects their willingness to become involved in epilepsy drug management and indicates the need for ongoing education and support to primary care practices. Furthermore, it was found that those patients who refused changes to their treatment regime feared the risk of break through seizures and the potential loss of their driving licence. This highlights the importance of initiating treatment with an appropriate AED at diagnosis as patients are unlikely to consider a change of medication once they are seizure free and have regained their driving license.
Evidence from the survey identified that 22.5% of the study population who were not receiving regular expert supervision were experiencing at least one seizure per month with several patients experiencing hundreds of seizures annually 5 .
The specialist review offered to patients was intended to be a one off review, with recommendation for change to be completed in the primary care setting so as not to strain the already stretched secondary care epilepsy services. It was felt however that a number of patients reviewed needed to come under the umbrella of secondary care due to poor fit control and side effects, and the need for complex medication changes, as well as the patients ongoing need for support to complete the recommended changes. It is therefore difficult to ascertain exactly how many patients completed all the recommended changes, and for those who did, to know how much better they were afterwards. We hope to address this with further research.
CONCLUSIONS
A well organised, local, secondary care epilepsy service with clear guidelines for referral and management of patients with epilepsy is still not sufficient to ensure patients in the local primary care setting will receive optimal management of their epilepsy. Education packages developed locally for general practitioners and practice nurses are needed to provide them with sufficient knowledge and confidence to make changes in drug regime or dosage to gain improved fit control, side effects and compliance.
Indeed patients often express the desire for their epilepsy care to be managed essentially in the primary care setting 12, 13 , although Chappell and Smithson 4 found that patients preferred the 'shared' care option. Jacoby et al. 9 found that GP confidence did affect their willingness to become involved in epilepsy treatment and have argued that improved care for epilepsy is dependent on increasing GP knowledge and confidence of the condition. An alternative option would be improving knowledge and confidence of practice nurses who are already accomplished at the management of chronic conditions including asthma and diabetes. With the support of a local epilepsy specialist nurse it may be possible for 'shared care' between primary and secondary care to be achieved 3, 14 .
Patients involved in this project, whether reviewed at their practice or the specialist review clinic, expressed delight that someone was taking an interest in their epilepsy, even if they chose to make no changes to their treatment. Further research is required to establish why people with poorly controlled epilepsy, or perceived side effects are not accessing primary care, or pressing for improvements in their epilepsy management.
